Skip to content

Success Stories

B-BIC: ‘IS MORE THAN JUST FUNDING’, with Kantum Pharma

We are thrilled to share with you a new web video we are releasing that highlights our ‘Commercialization Coaches’ and other services that are ways B-BIC successfully differentiates from other grants. Kantum Pharma, dedicated to the prevention and treatment of Acute Kidney Injury, received its first B-BIC Pilot grant in 2017.

Read More

Success Stories: B-BIC’s Work With Platelet Biogenesis

WATCH:  B-BIC’s Work With Platelet Biogenesis One of B-BIC’s first grant recipients was Jonathan Thon, a researcher based at Brigham and Women’s Hospital. Jonathan and his team had been researching two technologies necessary for producing platelets outside of the body. They had achieved promising results that demonstrated a microfluidic platform could simulate bone marrow physiological…

Read More

Success Story: Warren Zapol, David Zapol and Third Pole, Inc.

Approximately 10,000 “blue babies” are given inhaled nitric oxide (NO) to treat Hypoxic Respiratory Failure each year. Other potential uses for inhaled NO include heart attacks, strokes, and malaria. But the technology necessary to deliver inhaled NO is available only in a limited number of countries, for those who can afford it, with physicians who…

Read More

Success Story: Jonathan Thon and Platelet Biogenesis, Inc

Platelets are the ‘bandaids’ of the bloodstream. They are the cells in your blood that stop you from bleeding and transfusions save the lives of millions every year. However, platelets can only be stored for 5-7.5 days because of bacterial contamination issues. To manage this, blood centers typically don’t keep more than a 1.5 days…

Read More

New Awards: B-BIC Supports New Technologies For Commercial Development

RECIPIENT: Dr. Warren Zapol TITLE: Portable and Affordable Lightweight NO Generator TYPE OF AWARD:  DRIVE INSTITUTION: MGH DESCRIPTION:  Warren Zapol, MD, Director of the MGH Anesthesia Center for Critical Care Research at Massachusetts General Hospital, receives a DRIVE award to develop electric nitric oxide generation for medical purposes.  Inhaled nitric oxide (NO) was approved by the FDA…

Read More
Scroll To Top